Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103579535 | 10357953 | 5 | F | 19840413 | 20160630 | 20140801 | 20160706 | EXP | US-PFIZER INC-2014212629 | PFIZER | 26.00 | YR | F | Y | 46.71000 | KG | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103579535 | 10357953 | 1 | PS | DILANTIN | PHENYTOIN | 1 | Oral | 200MG CAPSULES ONE IN THE MORNING AND TWO AT NIGHT | U | 84349 | CAPSULE, HARD | BID | |||||||
| 103579535 | 10357953 | 2 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 3X/DAY | U | H79692 | 84349 | 100 | MG | CAPSULE, HARD | TID | ||||
| 103579535 | 10357953 | 3 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 2X/DAY | U | 84349 | 100 | MG | CAPSULE, HARD | BID | |||||
| 103579535 | 10357953 | 4 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 400 MG, 4X/DAY | 0 | 400 | MG | TABLET | QID | ||||||
| 103579535 | 10357953 | 5 | C | MOGADON | NITRAZEPAM | 1 | Oral | 25 MG, DAILY (5MG TABLETS, 2 PILLS IN THE MORNING, ONE PILL AT NOON AND 2 PILLS AT NIGHT) | 0 | 25 | MG | TABLET | |||||||
| 103579535 | 10357953 | 6 | C | MOGADON | NITRAZEPAM | 1 | 0 | TABLET | |||||||||||
| 103579535 | 10357953 | 7 | C | CENTRUM | VITAMINS | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | TABLET | QD | ||||||
| 103579535 | 10357953 | 8 | C | IRON | IRON | 1 | Oral | 325 MG, 3X/DAY | 0 | 325 | MG | TABLET | TID | ||||||
| 103579535 | 10357953 | 9 | C | ASA | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103579535 | 10357953 | 1 | Generalised tonic-clonic seizure |
| 103579535 | 10357953 | 4 | Seizure |
| 103579535 | 10357953 | 5 | Convulsion prophylaxis |
| 103579535 | 10357953 | 6 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103579535 | 10357953 | OT |
| 103579535 | 10357953 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103579535 | 10357953 | Bone disorder | |
| 103579535 | 10357953 | Condition aggravated | |
| 103579535 | 10357953 | Cutaneous lupus erythematosus | |
| 103579535 | 10357953 | Generalised tonic-clonic seizure | |
| 103579535 | 10357953 | Systemic lupus erythematosus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103579535 | 10357953 | 1 | 1979 | 0 | ||
| 103579535 | 10357953 | 2 | 19810629 | 0 | ||
| 103579535 | 10357953 | 4 | 197906 | 0 | ||
| 103579535 | 10357953 | 5 | 1985 | 0 |